Figure 2.
Figure 2. Cumulative incidence of pulmonary artery hypertension in CML patients treated with tyrosine kinase inhibitors

Cumulative incidence of pulmonary artery hypertension in CML patients treated with tyrosine kinase inhibitors

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal